USPTO serial 87668721
Serial No. 87668721
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Dec 1, 2020
- Examiner
- DICKEY, ERICA
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with Serial No. 87668721?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,446*
Plus Government fees of $1,300
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Sam Yip
Sam Yip Idea Intellectual LimitedNo. 49, Bo Ai Road, Zhongzheng District12F-1Taipei, 10044Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations and traditional Chinese medicine for the diagnosis, prevention and treatment of gastro-intestinal diseases and disorders; pharmaceutical preparations for the diagnosis, prevention and treatment of diseases and disorders relating to women's health, namely, gynecological diseases and disorders, endometrial disease and disorders; pharmaceutical products and preparations and traditional Chinese medicine for the treatment of orthopedic injuries and conditions; pharmaceutical preparations and traditional Chinese medicine for the diagnosis, prevention and treatment of ophthalmological diseases, conditions and disorders; pharmaceutical preparations and traditional Chinese medicine for the diagnosis, prevention and treatment of neurological diseases and disorders; pharmaceutical preparations and traditional Chinese medicine for the diagnosis, prevention and treatment of neurodegenerative diseases and disorders; pharmaceutical preparations and traditional Chinese medicine for the diagnosis, prevention and treatment of peripheral nervous system diseases and disorders; pharmaceutical preparations and traditional Chinese medicine for the diagnosis, prevention and treatment of cognitive deficiencies and neurodegenerative diseases and for the treatment of brain and spinal cord diseases or degenerative disorders and for improving neurological abilities | ACTIVE | — |
| 010 | Surgical apparatus and instruments for use in the field of gastro-intestinal medicine, orthopedics and ophthalmology; Medical apparatus and instruments, namely, surgical robotic apparatus and non-invasive detection tools in the nature of medical imaging devices for detecting brain plaques; medical and surgical apparatus, instruments and parts therefor for use in magnetic resonance imaging and other imaging-guided surgery, including markers for use in patient registration in the nature of procedures used in computer assisted surgeries and tracking the location of instruments within the patient's body during image guided surgeries; medical and surgical apparatus, instruments and parts therefor for use in minimum invasive surgery; medical apparatus for the treatment of neurodegenerative diseases; medical instruments and articles, namely, analytical apparatus for diagnosis of neurodegenerative diseases; analysis apparatus for medical purposes, namely, non-invasive detection apparatus probes and imaging devices for use in the fields of neurology and neurobiology; diagnostic apparatus for medical purposes, for diagnosing plagues and images in brain for use in the fields of neurology and neurobiology; medical diagnostic apparatus for the detection of neurodegenerative diseases and conditions; surgical, medical apparatus and instruments for the prevention, treatment and repair of neurodegenerative diseases and disorders; medical testing apparatus used for the treatment of cognitive deficiencies, neurodegenerative diseases and for the treatment of brain and spinal cord diseases or degenerative disorders and for improving neurological abilities | ACTIVE | — |
| 042 | Pre-clinical and clinical services for pharmaceutical and diagnostic test formulation research, namely, pharmacological studies, toxicokinetic and pharmacokinetic studies, toxicity tests, bioequivalence studies, stability tests, clinical trials, clinical research, medical research in the fields of gastro-intestinal medicine, women's health, orthopedics and ophthalmology; conducting clinical trials for diagnostic tests and for pharmaceutical preparations in the fields of gastro-intestinal medicine, women's health, orthopedics and ophthalmology; scientific and toxicology research services in the fields of gastro-intestinal medicine, women's health, orthopedics and ophthalmology; biopharmaceutical research for development of targeted therapies for use in the treatment of gastrointestinal diseases and disorders, diseases and disorders relating to woman's health, orthopedics and orthopedic injuries and conditions, and ophthalmological diseases, conditions and disorders; providing medical testing services for research purposes and medical and scientific research information in the fields of gastro-intestinal medicine, women's health, orthopedics and ophthalmology; pre-clinical and clinical services for formulation research, namely, pharmacological studies, toxicokinetic and pharmacokinetic studies, toxicity tests, bioequivalence studies, stability tests, clinical trials, clinical research, medical research in the field of neurodegenerative diseases; conducting clinical trials for diagnostic tests and for pharmaceutical preparations in the field of neurodegenerative diseases; scientific and toxicology research services in the field of neuroscience and neurodegenerative diseases; biopharmaceutical research for development of targeted therapies for use in the treatment of neurodegenerative diseases and disorders; providing medical testing services for research purposes and medical and scientific research information in the fields of degenerative and neurodegenerative diseases; consulting for pharmacology and medical toxicology in the fields of gastro-intestinal medicine, women's health, orthopedics and ophthalmology; consulting for pharmacology and toxicology in the field of neurodegenerative diseases and disorders | ACTIVE | — |
| 044 | Providing targeted, individualized treatment regimens, therapies or combination therapy for patients suffering from gastro-intestinal diseases and disorders, diseases and disorders relating to woman's health, orthopedics and orthopedic injuries and conditions, and ophthalmological diseases, conditions and disorders; medical testing for diagnostic or treatment purposes in the fields of gastro-intestinal medicine, women's health, orthopedics and ophthalmology; providing targeted, individualized treatment regimens, therapies or combination therapy for patients suffering from neurodegenerative diseases and disorders; medical testing for diagnostic or treatment purposes in the field of neurodegenerative diseases and disorders | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Aptorum Group Limited
- Other trademarks owned by Aptorum Group Limited
- Other trademarks owned by Aptorum Group Limited
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 042
- Other trademarks in Class 044
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 1, 2025 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Dec 1, 2020 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Oct 6, 2020 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Oct 6, 2020 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Oct 6, 2020 | EWOR | TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED | — |
| Oct 6, 2020 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 6, 2020 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Oct 6, 2020 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Sep 15, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 15, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 26, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 7, 2020 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jul 30, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 23, 2020 | OTHE | CASE RETURNED TO EXAMINATION | — |
| Jul 23, 2020 | IUCN | NOTICE OF ALLOWANCE CANCELLED | — |
| Jul 23, 2020 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Jun 11, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 11, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 10, 2020 | EXT1 | SOU EXTENSION 1 FILED | — |
| Jun 10, 2020 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jun 9, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 7, 2020 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 7, 2020 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 7, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 28, 2020 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Apr 10, 2020 | ATRQ | ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED | — |
| Apr 10, 2020 | PCBG | PETITION TO DIRECTOR - CHANGE BASIS - GRANTED | — |
| Apr 10, 2020 | APET | ASSIGNED TO PETITION STAFF | — |
| Mar 10, 2020 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Feb 6, 2020 | 44EP | 44(e) PETITION - RECEIVED | — |
| Feb 6, 2020 | EPPA | TEAS POST PUBLICATION AMENDMENT RECEIVED | — |
| Dec 10, 2019 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Oct 15, 2019 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 15, 2019 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 25, 2019 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 6, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 6, 2019 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Sep 6, 2019 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Sep 6, 2019 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Sep 6, 2019 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Aug 26, 2019 | GPRN | NOTIFICATION OF PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Aug 26, 2019 | GPRA | PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Aug 26, 2019 | CPRA | PRIORITY ACTION WRITTEN | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Aug 2, 2019 | NREV | NOTICE OF REVIVAL - E-MAILED | — |
| Aug 2, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 2, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 2, 2019 | ALIE | ASSIGNED TO LIE | — |
| Aug 2, 2019 | PGRR | PETITION GRANTED - RESPONSE RECEIVED | — |
| Jul 30, 2019 | APET | ASSIGNED TO PETITION STAFF | — |
| Jun 8, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 8, 2019 | PROA | TEAS PETITION TO REVIVE RECEIVED | — |
| Dec 7, 2018 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 7, 2018 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 7, 2018 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 13, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 12, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 12, 2018 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Sep 5, 2018 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Sep 5, 2018 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Sep 5, 2018 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Aug 15, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 14, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 14, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 14, 2018 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 14, 2018 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 14, 2018 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 12, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 14, 2017 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Nov 11, 2017 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 4, 2017 | NWAP | NEW APPLICATION ENTERED | — |